Health Care & Life Sciences » Pharmaceuticals | Jiangsu Kanion Pharmaceutical Co. Ltd.

Jiangsu Kanion Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Jiangsu Kanion Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
4,097,892
0.69%
0
0.09%
12/31/2017
Nanfang CSI 500 ETF
1,831,085
0.31%
-186,035
0.14%
12/31/2017
Everbright Pramerica Quantitative Core Fund
1,573,667
0.26%
1,573,667
0.75%
12/31/2017
1,296,462
0.22%
0
0.03%
12/31/2017
1,280,000
0.21%
0
1.5%
12/31/2017
Caisse de Dépôt & Placement du Québec
1,217,698
0.2%
767,698
0%
12/31/2017
1,040,051
0.17%
-69,175
0.75%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
781,984
0.13%
0
0%
07/31/2018
526,240
0.09%
526,240
0.21%
12/31/2017
298,300
0.05%
298,300
0.56%
12/31/2017

About Jiangsu Kanion Pharmaceutical Co.

View Profile
Address
Jiangning Industrial City
Lianyungang Jiangsu 222047
China
Employees -
Website http://www.kanion.com
Updated 07/08/2019
Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese medicine pretreatment and extraction. It focuses on respiratory, gynecological, cardiovascular, and orthopedic disease. The company was founded on December 2, 2000 and is headquartered in Lianyungang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.